Importantly, higher NKG2C levels were positively associated with EDSS, suggesting that MS patients expressing higher levels of the NKG2C receptor are characterized by disease progression and the accumulation of disability over time. The gene discussed is KLRC2; the disease is myeloid sarcoma.